Fortress Biotech, Inc.
NASDAQ:FBIO
1.84 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||
| Net Income
| -60.637 | -213.913 | -164.826 | -102.985 | -101.66 | -130.8 | -99.836 | -71.29 | -53.883 | -20.386 | -37.158 | -27.61 | -36.36 | -9.982 |
| Depreciation & Amortization
| 8.075 | 9.353 | 6.791 | 5.325 | 4.654 | 2.059 | 3.35 | 1.127 | 0.026 | 0.023 | 0.017 | 0.003 | 0.022 | 0.005 |
| Deferred Income Tax
| 7.878 | 0 | -38.799 | -5.18 | -18.349 | 0.287 | -8.558 | -0.073 | 2.113 | -0.22 | 0 | 0 | 36.338 | 0.234 |
| Stock Based Compensation
| 17.029 | 22.987 | 19.486 | 13.451 | 13.188 | 15.012 | 14.005 | 12.128 | 14.291 | 5.546 | 5.902 | 3.638 | 1.469 | 2.329 |
| Change In Working Capital
| -12.519 | -0.715 | 36.373 | -4.781 | -4.841 | 5.736 | -2.233 | 1.971 | 5.188 | -1.533 | 1.057 | -0.398 | 1.774 | 0.318 |
| Accounts Receivables
| 12.522 | -5.38 | 0.768 | -5.859 | -8.141 | 2.26 | -5.928 | -1.83 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 3.953 | 1.744 | -8.458 | -0.547 | -0.179 | -0.507 | 0.032 | -0.203 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -24.382 | 8.349 | 43.307 | 6.522 | 1.946 | 4.663 | 9.899 | 5.395 | 5.889 | -0.849 | 1.184 | -0.26 | -0.046 | 0.407 |
| Other Working Capital
| -4.612 | -5.428 | 0.756 | -4.897 | 1.533 | -0.68 | -6.236 | -1.391 | -0.701 | -0.684 | -0.127 | -0.138 | 1.82 | -0.089 |
| Other Non Cash Items
| -88.051 | 2.887 | 24.435 | 10.488 | 12.047 | 8.858 | 7.842 | 10.324 | 11.887 | 0.236 | 0.536 | 1.173 | -14.195 | 1.419 |
| Operating Cash Flow
| -128.225 | -179.401 | -116.54 | -83.682 | -94.961 | -98.848 | -85.43 | -45.813 | -20.378 | -16.334 | -29.646 | -23.194 | -10.952 | -5.677 |
| Investing Activities: | ||||||||||||||
| Investments In Property Plant And Equipment
| -8.098 | -3.055 | -16.346 | -7.164 | -9.395 | -9.356 | -5.445 | -10.505 | -11.981 | 0 | -0.188 | -0.279 | -3.843 | -0.013 |
| Acquisitions Net
| 6 | -20 | 56.86 | 0 | -1.201 | 2.274 | -0.019 | 4.451 | -11.698 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | -5 | -52.604 | -56.091 | -0.181 | -79.947 | -23.273 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 22.604 | 71.002 | 20.089 | 0 | 99.949 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.005 | 0.127 | 45.08 | -5.238 | 13.089 | 7.508 | -0.163 | -0.006 | 11.562 | -23.273 | -0.188 | -0.279 | -3.843 | -0.013 |
| Investing Cash Flow
| -2.103 | -22.928 | 40.514 | -7.164 | 20.097 | 18.824 | -41.629 | -6.06 | 7.885 | -23.273 | -0.188 | -0.279 | -3.843 | -0.013 |
| Financing Activities: | ||||||||||||||
| Debt Repayment
| -39.794 | -2.864 | -15.75 | -89.671 | -21.874 | -17.299 | -3.608 | -6.392 | -9.145 | -0.355 | -1.345 | -0.75 | 0 | -0.65 |
| Common Stock Issued
| 81.701 | 40.432 | 172.807 | 178.061 | 137.509 | 37.965 | 95.307 | 40.285 | 57.876 | 4.117 | 92.399 | 28.855 | 0.193 | 0 |
| Common Stock Repurchased
| -0.4 | -1.196 | 0 | -0.07 | -0.024 | -0.234 | 1.682 | 0 | 0 | 0 | -1.898 | -2.305 | -2.884 | -2.291 |
| Dividends Paid
| -8.768 | -8.78 | -8.78 | -6.752 | -2.559 | -2.344 | -0.299 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -1.089 | 47.727 | 172.775 | 90.842 | 33.662 | 35.693 | 61.125 | 8.092 | 3.04 | -10.51 | 1.898 | 32.017 | 25.784 | 21.983 |
| Financing Cash Flow
| 32.739 | 75.319 | 148.994 | 172.41 | 146.714 | 50.648 | 154.207 | 41.985 | 60.916 | -10.155 | 89.156 | 40.512 | 23.093 | 19.042 |
| Other Information: | ||||||||||||||
| Effect Of Forex Changes On Cash
| -33.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -97.339 | -127.01 | 72.968 | 81.564 | 71.85 | -29.376 | 27.148 | -9.888 | 48.423 | -49.762 | 59.322 | 17.039 | 8.298 | 13.352 |
| Cash At End Of Period
| 80.927 | 180.954 | 307.964 | 234.996 | 153.432 | 81.582 | 131.302 | 88.294 | 98.182 | 49.759 | 99.521 | 40.199 | 23.16 | 14.862 |